Results 181 to 190 of about 43,677 (218)
Some of the next articles are maybe not open access.
2002
Abstract The pharmacology of acetylcholine is in many ways a very old subject. The use of antimuscarinic plant extracts as both poisons and therapies can be traced back to ancient times. Thus, Linnaeus gave the systematic name Atropa belladonna to the deadly nightshade, in homage to Atropos of Greek mythology, who cuts the thread of life,
openaire +1 more source
Abstract The pharmacology of acetylcholine is in many ways a very old subject. The use of antimuscarinic plant extracts as both poisons and therapies can be traced back to ancient times. Thus, Linnaeus gave the systematic name Atropa belladonna to the deadly nightshade, in homage to Atropos of Greek mythology, who cuts the thread of life,
openaire +1 more source
CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment
This review explores the main aspects that form the basis of the cholinergic-oriented treatment of Alzheimer disease. Muscarinic acetylcholine receptor subtypes in the brain and periphery are discussed. It includes a new and updated overview of the involvement of muscarinic receptors in Alzheimer disease and the recent development of new and highly ...Abraham, Fisher, Allan I, Levey
openaire +2 more sources
Muscarinic Receptor Antagonists
Pulmonary Pharmacology & Therapeutics, 1999N, Watson, R M, Eglen
openaire +2 more sources
Axoplasmic transport of muscarinic receptors
Nature, 1980The reality of axoplasmic transport is widely accepted; various neutrotransmitters, enzymes, labelled proteins and peptides are known to move rapidly along the axons of different nerve fibres. In the terminals of sympathetic nerves, noradrenaline release is controlled by various regulatory mechanisms which imply the occurrence of presynaptic receptors.
openaire +2 more sources
Therapeutic opportunities from muscarinic receptor research
Trends in Pharmacological Sciences, 2001N Watson, R M Eglen
exaly
Muscarinic acetylcholine receptors: novel opportunities for drug development
Nature Reviews Drug Discovery, 2014Andrew C Kruse +2 more
exaly